A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Trifluperidol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Trifluperidol.
2,5-Dimethoxyamphetamine
Iprazochrome
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Iprazochrome.
2,5-Dimethoxyamphetamine
Gedocarnil
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Gedocarnil.
2,5-Dimethoxyamphetamine
Veralipride
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Veralipride.
2,5-Dimethoxyamphetamine
Mebicar
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Mebicar.
2,5-Dimethoxyamphetamine
Metergoline
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Metergoline.
2,5-Dimethoxyamphetamine
Emepronium
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Emepronium.
2,5-Dimethoxyamphetamine
Oxaflozane
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Oxaflozane.
2,5-Dimethoxyamphetamine
Phenibut
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Phenibut.
2,5-Dimethoxyamphetamine
Medazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Medazepam.
2,5-Dimethoxyamphetamine
Thiazinam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Thiazinam.
2,5-Dimethoxyamphetamine
Fenyramidol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fenyramidol.
2,5-Dimethoxyamphetamine
Oxypertine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Oxypertine.
2,5-Dimethoxyamphetamine
Acetylglycinamide chloral hydrate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Acetylglycinamide chloral hydrate.
2,5-Dimethoxyamphetamine
Neocitrullamon
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Neocitrullamon.
2,5-Dimethoxyamphetamine
Chlorproethazine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Chlorproethazine.
2,5-Dimethoxyamphetamine
Vinbarbital
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Vinbarbital.
2,5-Dimethoxyamphetamine
Bromisoval
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Bromisoval.
2,5-Dimethoxyamphetamine
Pheneturide
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Pheneturide.
2,5-Dimethoxyamphetamine
Styramate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Styramate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3